You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Breast cancer

Denosumab for the prevention of skeletal-related events in adults with bone metastases from solid tumours

  • Technology appraisal guidance
  • Reference number: TA265
  • Published:  24 October 2012
  • Guidance
  • Tools and resources
  • Information for the public
  • History

Bone metastases from solid tumours - denosumab: appeal from Prostate Cancer Support Federation

  • Bone metastases from solid tumours - denosumab: Prostate Cancer Support Federation - appeal received

  • Bone metastases from solid tumours - denosumab: Prostate Cancer Support Federation - initial scrutiny letter

  • Bone metastases from solid tumours - denosumab: Prostate Cancer Support Federation - response to scrutiny letter

  • Bone metastases from solid tumours - denosumab: Prostate Cancer Support Federation - final scrutiny letter


This page was last updated: 18 October 2012

Back to top